These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28672139)

  • 21. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB; Patnaik M
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of recombinant activated factor VII in neurosurgery.
    Kapapa T; König K; Heissler HE; Schatzmann C; Tschan CA; Perl M; von Depka M; Zumkeller M; Rickels E
    Surg Neurol; 2009 Feb; 71(2):172-9; discussion 179. PubMed ID: 18295827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
    Giangrande PL; Wilde JT; Madan B; Ludlam CA; Tuddenham EG; Goddard NJ; Dolan G; Ingerslev J
    Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
    Miyata N; Isaka M; Kojima H; Maniwa T; Takahashi S; Takamiya O; Ohde Y
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):177-80. PubMed ID: 25056454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-heart surgery in an infant with heterozygous factor VII deficiency.
    Matsuhisa H; Yoshimura N; Niimi H; Ichida F
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1037-8. PubMed ID: 20197348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures.
    Di Minno MND; Ambrosino P; Myasoedova V; Amato M; Ventre I; Tremoli E; Minno AD
    Curr Pharm Des; 2017; 23(7):1125-1131. PubMed ID: 28034354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports].
    Moravcsik B; Nemes L; Zsiros L
    Orv Hetil; 2008 Aug; 149(33):1565-8. PubMed ID: 18687576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report.
    Pirrello R; Siragusa S; Giambona C; D'Arpa S; Cordova A; Moschella F
    Cleft Palate Craniofac J; 2006 Jan; 43(1):108-11. PubMed ID: 16405366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
    Goksedef D; Panagopoulos G; Nassiri N; Levine RL; Hountis PG; Plestis KA
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1198-204. PubMed ID: 22285329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with activated factor VII: focus on safety aspects.
    Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S115-8. PubMed ID: 9819041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VII deficiency first observed at preoperative routine clotting test.
    Yoshioka H; Kogo M; Iida S; Taki T; Kawamoto M; Matsuya T
    J Osaka Univ Dent Sch; 1990 Dec; 30():157-60. PubMed ID: 2151820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
    Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G
    Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
    Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
    Guzzetta NA; Russell IA; Williams GD
    Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.